BHVN
Biohaven Ltd.NYSEHealthcare$9.80+1.87%ClosedMarket Cap: $1.04B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
22.62
P/S
0.00
EV/EBITDA
-1.46
DCF Value
$-0.55
FCF Yield
-58.8%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-688.9%
ROA
-171.2%
ROIC
-222.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-142.7M | $-145.6M | $-1.21 | — |
| FY 2025 | $0.00 | -Infinity% | $-745.4M | $-738.8M | $-6.86 | — |
| Q3 2025 | $0.00 | -Infinity% | $-169.4M | $-173.4M | $-1.64 | — |
| Q2 2025 | $0.00 | NaN% | $-211.7M | $-198.1M | $-1.94 | — |
| Q1 2025 | $0.00 | NaN% | $-221.6M | $-221.7M | $-2.17 | — |
| Q4 2024 | $0.00 | NaN% | $-189.9M | $-186.8M | $-1.85 | — |
| FY 2024 | $0.00 | NaN% | $-885.1M | $-846.4M | $-9.28 | — |
| Q3 2024 | $0.00 | NaN% | $-178.2M | $-160.3M | $-1.70 | — |
| Q2 2024 | $0.00 | NaN% | $-333.8M | $-319.8M | $-3.64 | — |
| Q1 2024 | $0.00 | NaN% | $-183.2M | $-179.5M | $-2.20 | — |
| Q4 2023 | $0.00 | -Infinity% | $-153.7M | $-144.8M | $-1.81 | — |
| FY 2023 | $0.00 | NaN% | $-436.1M | $-408.2M | $-5.73 | — |